ISHITA ACTIVE PHARMA INGREDIENTS (API) PVT LTD is the sister concern of Ishita Plastics which was founded and laid by Mr. Rajesh Shah since the year 1987. Since the day of its establishment the company under the guidance of its founder has been achieving an exponential and sustained growth.
Ishita API which was founded in 2012 and is a professionally managed manufacturing company producing Bulk Drugs, Intermediates and Specialty Chemicals. Our area of Expertise is in Antiepileptic Drugs and Analgesic Drugs. In the very first year of its inception, all its products were approved by major domestic pharmaceutical companies.
With our continuous research and expert scientists, we are able to provide better quality. Ishita API is working on different models of business. We design our products and get the same manufactured through Contract Manufacturing. We have our own QA and QC Laboratory. Marketing is our strength and we keep the sole marketing rights of our products with us. To have our PAN India Presence, Ishita API has appointed agents across India.
The Company is managed by Mr. Rajesh Shah (Founder and Chairman of Ishita API Pvt Ltd) and Mr. Nandish Shah (Managing Director of Ishita API Pvt Ltd). Mr. Rajesh Shah has a very wide experience in the Pharma Industry. Since 1987, he has been dealing in the Pharma Industry. His main business is packing material of Pharma Industry which includes Pharma & Blister Foil along with PVC and all other form of packing. Since last one decade, we are also into API Trading business in the name of Polypharma Drug House. In this business, we have the agencies of some of the big API Manufacturers of India.
For the last two years, Mr. Nandish Shah has started getting the manufacturing of APIs done, for which the market analysis and R & D is done in-house.
Our Vision is to establish our own FDA Approved, WHO-GMP Certified manufacturing plant producing Bulk Drugs and Intermediates.
By this we wish to provide a worldwide industrial network and a dedicated regulatory support.
To develop and manufacture Active Pharmaceutical Ingredients (APIs) and Intermediates for global supply, complying with quality and regulatory requirements of our customers.